SCHEMBL1116262

SCHEMBL1116262

COc1ccc(-c2ccc(/C=C3/N=C(N)NC3=O)o2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR2A P28223 4/20 0.54
▸ ALOX5 P09917 1/20 0.46
▸ CA1 P00915 1/20 0.45
▸ CA2 P00918 1/20 0.45
▸ CLK1 P49759 1/20 0.45
▸ CLK2 P49760 1/20 0.45
▸ CLK4 Q9HAZ1 1/20 0.45
▸ PIK3CG P48736 1/20 0.43
▸ HPGD P15428 2/20 0.43
▸ MAPT P10636 1/20 0.43
▸ SIRT2 Q8IXJ6 1/20 0.42
▸ BRAF P15056 1/20 0.42
▸ MAP3K5 Q99683 1/20 0.41
▸ IGF1R P08069 1/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ MITF O75030 1/20 0.41
▸ ALDH1A1 P00352 2/20 0.40
▸ G6PD P11413 1/20 0.40
▸ GFER P55789 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1116264 1.00 HTR2A (0.54) HTR2AALOX5CA1CA2CLK1
SCHEMBL1116164 0.83 HTR2A (0.60) HTR2ACA1CA2CLK1CLK2
SCHEMBL1116160 0.83 HTR2A (0.60) HTR2ACA1CA2CLK1CLK2
SCHEMBL1116040 0.82 HTR2A (0.51) HTR2ACA1CA2CLK1CLK2
SCHEMBL1116037 0.82 HTR2A (0.51) HTR2ACA1CA2CLK1CLK2
SCHEMBL1228305 0.80 BRAF (0.60) PIK3CGMAPTBRAFMEN1KMT2A
SCHEMBL1228309 0.80 BRAF (0.60) PIK3CGMAPTBRAFMEN1KMT2A
SCHEMBL1116163 0.77 HTR2A (0.42) HTR2ACA1CA2CLK1CLK2
SCHEMBL12899354 0.77 HTR2A (0.50) HTR2ACA1CA2CLK1CLK2
SCHEMBL1116161 0.77 HTR2A (0.42) HTR2ACA1CA2CLK1CLK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011015646-A2 FURAN-IMIDAZOLONE DERIVATIVES, FOR THE TREATMENT OF COGNITIVE, NEURODEGENERATIVE OR NEURONAL DISEASES OR DISORDERS NOSCIRA, S.A. (ES) 2011-02-10 — — WO disclosed
WO-2011015646-A2 FURAN-IMIDAZOLONE DERIVATIVES, FOR THE TREATMENT OF COGNITIVE, NEURODEGENERATIVE OR NEURONAL DISEASES OR DISORDERS NOSCIRA, S.A. (ES) 2011-02-10 — — WO disclosed
EP-2281824-A1 Furan-imidazolone derivatives, for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders NOSCIRA, S.A. (ES) 2011-02-09 — — EP disclosed
EP-2281824-A1 Furan-imidazolone derivatives, for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders NOSCIRA, S.A. (ES) 2011-02-09 — — EP disclosed
Send feedback